Psoriatic Arthritis
Conference Coverage
Ultrasound’s role in detecting enthesitis in psoriatic arthritis remains debatable
Key clinical point: Ultrasound can diagnose enthesitis in psoriatic arthritis, but findings differ from physical exam. Major finding: Multivariate...
Conference Coverage
Psoriatic flare assessment tool in validation stage
MIAMI – Reaching consensus on measurement and assessment of flare in psoriatic arthritis remains challenging, especially with no widely accepted...
Conference Coverage
Psoriatic arthritis patients face more endocrine comorbidities
MIAMI – Diabetes mellitus, hypothyroidism, Cushing’s disease, and osteoporosis occur more frequently in people with psoriatic arthritis than in...
Conference Coverage
Benefits, challenges emerge in evolution of rheumatology-dermatology clinics
Conference Coverage
Psoriatic arthritis patients have elevated risk for coronary artery plaque
Key clinical point:Imaging reveals a higher rate and greater extent of coronary plaque in people with psoriatic arthritis versus healthy controls...
News
Brodalumab approval recommended, despite possible suicide signal
An FDA advisory committee has supported approval of the monoclonal antibody brodalumab for treating moderate to severe plaque psoriasis.
News
FDA advisory panel unanimously backs biosimilars for Humira, Enbrel
Conference Coverage
Severe psoriasis upped lymphoma risk in large cohort study
SCOTTSDALE, ARIZ. – Psoriasis of all severities was linked to a 3.5-fold increase in risk of cutaneous T-cell lymphoma, and severe psoriasis upped...
Conference Coverage
Analysis supports daily folate for children with psoriasis on methotrexate
Key clinical point: Consider daily folate to reduce the likelihood of gastrointestinal side effects of methotrexate in children with psoriasis....
News
Significant race and health care disparities exist among hospitalized psoriasis patients
Conference Coverage
Obesity may attenuate anti-TNF response in psoriatic arthritis
LONDON – Patients with psoriatic arthritis appear less likely to achieve a good response to their first anti-tumor necrosis factor therapy if they...